- Home
- HFBL vs LTRN Comparison
HFBL vs LTRN Comparison
Compare HFBL & LTRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | HFBL | LTRN |
|---|---|---|
| Founded | 1924 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Savings Institutions | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 41.6M | 49.9M |
| IPO Year | N/A | 2020 |
Fundamental Metrics
Financial Performance| Metric | HFBL | LTRN |
|---|---|---|
| Price | $16.59 | $3.48 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $25.00 |
| AVG Volume (30 Days) | 3.7K | ★ 61.0K |
| Earning Date | 01-29-2026 | 11-12-2025 |
| Dividend Yield | ★ 3.25% | N/A |
| EPS Growth | ★ 35.20 | N/A |
| EPS | ★ 1.47 | N/A |
| Revenue | ★ $21,720,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $11.30 | ★ N/A |
| Revenue Growth | ★ 10.10 | N/A |
| 52 Week Low | $12.31 | $2.55 |
| 52 Week High | $19.20 | $6.12 |
Technical Indicators
Market Signals| Indicator | HFBL | LTRN |
|---|---|---|
| Relative Strength Index (RSI) | 52.42 | 47.50 |
| Support Level | $16.45 | $3.19 |
| Resistance Level | $17.25 | $3.72 |
| Average True Range (ATR) | 0.97 | 0.27 |
| MACD | -0.06 | -0.00 |
| Stochastic Oscillator | 44.82 | 32.72 |
Price Performance
Historical ComparisonAbout HFBL Home Federal Bancorp Inc. of Louisiana
Home Federal Bancorp Inc of louisiana operates as a bank holding company. It is a federally chartered stock savings bank, which provides financial services to individuals, corporate entities, and other organizations. Its core activities consist of attracting deposits from the general public and using those funds to originate loans to the residential, commercial and multi-family segments. The company also invests securities held-to-maturity and securities available for sale.
About LTRN Lantern Pharma Inc.
Lantern Pharma Inc is an AI company transforming the cost, pace, and timeline of oncology drug discovery and development. Its proprietary AI and machine learning (ML) platform, RADR, uses oncology-focused data points and advanced ML algorithms to solve billion-dollar, real-world problems in cancer drug development. The group's growing pipeline of precision therapies has been accelerated using AI and input from world-class scientific advisors and collaborators.